And Pluvy et al. [67] reported a case of using nivolumab (a PD-1 blocking antibody) combined with sirolimus for treating metastatic lung adenocarcinoma in a patient with sporadic LAM. Here, PDCD1 is linked to lymphangioleiomyomatosis.